Back in March 2021, Vitaccess joined forces with Source Health Economics, JG ZEBRA CONSULTING LTD, HCD Economics Ltd, University of Leicester, University of York and The University of Sheffield to host a webinar about “Economic Modelling in Rare Diseases”.

It can be challenging to develop an economic model in rare diseases that optimises HTA and reimbursement outcomes. It can also be difficult to fully capture the effects of the disease and the benefits of treatment whilst using sufficiently robust data to minimise uncertainty. To find out more, watch the webinar and Dr Mark Larkin’s presentation from 45m27s.

Skip to content